PureTech Health plc (LON: PRTC)
London
· Delayed Price · Currency is GBP · Price in GBX156.40
+1.80 (1.16%)
Dec 23, 2024, 5:07 PM BST
PureTech Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 0.47 | 3.33 | 15.62 | 17.39 | 11.77 | 9.81 | Upgrade
|
| Revenue Growth (YoY) | -96.01% | -78.68% | -10.18% | 47.76% | 20.00% | -52.73% | Upgrade
|
| Cost of Revenue | 82.02 | 96.24 | 152.43 | 110.47 | - | 85.85 | Upgrade
|
| Gross Profit | -81.55 | -92.91 | -136.82 | -93.08 | 11.77 | -76.04 | Upgrade
|
| Selling, General & Admin | 54.89 | 53.3 | 60.99 | 57.2 | 49.44 | 59.36 | Upgrade
|
| Research & Development | - | - | - | - | 81.86 | - | Upgrade
|
| Operating Expenses | 54.89 | 53.3 | 60.99 | 57.2 | 131.3 | 59.36 | Upgrade
|
| Operating Income | -136.44 | -146.2 | -197.81 | -150.28 | -119.53 | -135.4 | Upgrade
|
| Interest Expense | -20.05 | -13.49 | -3.95 | -4.71 | -2.95 | -4.1 | Upgrade
|
| Interest & Investment Income | 20.01 | 16.01 | 5.8 | 0.21 | 1.18 | 4.36 | Upgrade
|
| Earnings From Equity Investments | -14.06 | -33.69 | -27.75 | -73.7 | -34.12 | 30.79 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.05 | -0.09 | 0.01 | -0.06 | - | 0.07 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.84 | 1.74 | 144.66 | 11.2 | -3.32 | -46.44 | Upgrade
|
| EBT Excluding Unusual Items | -151.43 | -175.71 | -79.04 | -217.34 | -158.73 | -150.72 | Upgrade
|
| Gain (Loss) on Sale of Investments | 74.04 | 77.82 | -41.53 | 158.39 | 177.7 | 364.78 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 61.79 | 27.25 | - | - | 264.41 | Upgrade
|
| Other Unusual Items | - | - | 0.54 | - | - | - | Upgrade
|
| Pretax Income | -77.39 | -36.1 | -92.78 | -58.95 | 18.97 | 478.47 | Upgrade
|
| Income Tax Expense | 12.57 | 30.53 | -55.72 | 3.76 | 14.4 | 112.41 | Upgrade
|
| Earnings From Continuing Operations | -89.96 | -66.63 | -37.06 | -62.71 | 4.57 | 366.07 | Upgrade
|
| Net Income to Company | -89.96 | -66.63 | -37.06 | -62.71 | 4.57 | 366.07 | Upgrade
|
| Minority Interest in Earnings | 7.5 | 0.93 | -13.29 | 2.15 | 1.42 | 55.08 | Upgrade
|
| Net Income | -82.47 | -65.7 | -50.35 | -60.56 | 5.99 | 421.14 | Upgrade
|
| Net Income to Common | -82.47 | -65.7 | -50.35 | -60.56 | 5.99 | 421.14 | Upgrade
|
| Net Income Growth | - | - | - | - | -98.58% | - | Upgrade
|
| Shares Outstanding (Basic) | 272 | 276 | 285 | 287 | 286 | 283 | Upgrade
|
| Shares Outstanding (Diluted) | 272 | 276 | 285 | 287 | 293 | 292 | Upgrade
|
| Shares Change (YoY) | -2.86% | -2.97% | -0.64% | -2.14% | 0.37% | 6.55% | Upgrade
|
| EPS (Basic) | -0.30 | -0.24 | -0.18 | -0.21 | 0.02 | 1.49 | Upgrade
|
| EPS (Diluted) | -0.30 | -0.24 | -0.18 | -0.21 | 0.02 | 1.44 | Upgrade
|
| EPS Growth | - | - | - | - | -98.61% | - | Upgrade
|
| Free Cash Flow | -120.8 | -105.99 | -180.97 | -163.85 | -137 | -110.29 | Upgrade
|
| Free Cash Flow Per Share | -0.44 | -0.38 | -0.64 | -0.57 | -0.47 | -0.38 | Upgrade
|
| Gross Margin | - | - | - | - | 100.00% | - | Upgrade
|
| Operating Margin | -29152.99% | -4390.39% | -1266.53% | -864.29% | -1015.73% | -1380.64% | Upgrade
|
| Profit Margin | -17620.94% | -1972.88% | -322.41% | -348.27% | 50.86% | 4294.32% | Upgrade
|
| Free Cash Flow Margin | -25811.54% | -3182.79% | -1158.71% | -942.29% | -1164.15% | -1124.65% | Upgrade
|
| EBITDA | -134.73 | -143.25 | -191.96 | -145.93 | -115.59 | -132.05 | Upgrade
|
| D&A For EBITDA | 1.71 | 2.95 | 5.85 | 4.35 | 3.95 | 3.35 | Upgrade
|
| EBIT | -136.44 | -146.2 | -197.81 | -150.28 | -119.53 | -135.4 | Upgrade
|
| Effective Tax Rate | - | - | - | - | 75.92% | 23.49% | Upgrade
|
| Revenue as Reported | 0.47 | 3.33 | 15.62 | 17.39 | 11.77 | 9.81 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.